MedTrace Logo

Accuracy and User Performance Evaluation of PixoTest HbA1c Measurement System

NCT06575231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-28

No results posted yet for this study

Summary

To evaluate the accuracy user performance of PixoTest HbAc1 measurement system and to collect feedback from subjects.

Conditions

Interventions

DIAGNOSTIC_TEST

in-vitro

responding smartphone. It is intended for quantitative measurement of HbA1c in capillary whole blood and use in the home by people with diabetes mellitus as an aid to monitor the effectiveness of diabetes control.

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Shi-Yann Cheng, M.D · China Medical University Beigang Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2017-05-17
Completion
2017-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06575231 on ClinicalTrials.gov